Vir Biotechnology (VIR) FCF Margin Growth (1y) (2019 - 2026)
Vir Biotechnology (VIR) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | -45.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.52 Mn |
| Dec 31, 2025 | 68,341.00 |
| Sep 30, 2025 | -6.26 Mn |
| Jun 30, 2025 | -755,851.00 |
| Mar 31, 2025 | -241,491.00 |
| Dec 31, 2024 | -7,228.00 |
| Sep 30, 2024 | -127,576.00 |
| Jun 30, 2024 | 794,723.00 |
| Mar 31, 2024 | -451.00 |
| Dec 31, 2023 | -69,771.00 |
| Sep 30, 2023 | -607,199.00 |
| Jun 30, 2023 | -1.28 Mn |
| Mar 31, 2023 | -25,405.00 |
| Dec 31, 2022 | 4,686.00 |
| Sep 30, 2022 | 13,017.00 |
| Jun 30, 2022 | 223,051.00 |
| Mar 31, 2022 | 459,330.00 |
| Dec 31, 2021 | 451,521.00 |
| Sep 30, 2021 | 267,881.00 |
| Jun 30, 2021 | 10,606.00 |